RA Capital leads Series C round for Ivantis

Irvine, California-based Ivantis Inc, a developer of a device for glaucoma patients, has raised $25 million in Series C funding. RA Capital Management led the round with participation from other backers that included Mérieux Développement.

9 January 2017•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail